Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -42,184 | -52,412 | -87,688 | -51,610 | -24,886 |
| Depreciation Amortization | 1,072 | 3,133 | 2,207 | 1,286 | 538 |
| Accounts receivable | 75,000 | -75,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -811 | -410 | -1,693 | -4,045 | -2,338 |
| Other Working Capital | 78,081 | -85,170 | 848 | 1,659 | 559 |
| Other Operating Activity | -64,518 | 107,370 | 19,109 | 9,532 | 3,793 |
| Operating Cash Flow | $46,640 | $-102,489 | $-67,217 | $-43,178 | $-22,334 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 386,175 | 350,058 | 300,056 | 210,556 | 107,000 |
| PPE Investments | -476 | -1,931 | -1,867 | -1,434 | -1,020 |
| Purchase Of Investment | -619,320 | -266,455 | -140,097 | -71,103 | -55,609 |
| Investing Cash Flow | $-233,621 | $81,672 | $158,092 | $138,019 | $50,371 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,055 | 426,509 | 428,960 | 718 | 351 |
| Other Financing Activity | 0 | 0 | -2,507 | -460 | 0 |
| Financing Cash Flow | $2,055 | $426,509 | $426,453 | $258 | $351 |
| Beginning Cash Position | 448,524 | 42,832 | 42,832 | 42,832 | 42,832 |
| End Cash Position | 263,598 | 448,524 | 560,160 | 137,931 | 71,220 |
| Net Cash Flow | $-184,926 | $405,692 | $517,328 | $95,099 | $28,388 |
| Free Cash Flow | |||||
| Operating Cash Flow | 46,640 | -102,489 | -67,217 | -43,178 | -22,334 |
| Capital Expenditure | -476 | -1,931 | -1,867 | -1,434 | -1,020 |
| Free Cash Flow | 46,164 | -104,420 | -69,084 | -44,612 | -23,354 |